C1QTNF9B
Complement C1q and tumor necrosis factor-related protein 9B
Also known as: C1T9B_HUMAN, CTRP9B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- B2RNN3
- Gene
- C1QTNF9B
- Ensembl
- ENSG00000205863
- Chromosome
- 13
- Canonical length
- 333 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted - unknown location
OverviewNCBI Gene
Predicted to enable hormone activity and identical protein binding activity. Predicted to act upstream of or within several processes, including negative regulation of cell size; positive regulation of cellular response to insulin stimulus; and positive regulation of protein serine/threonine kinase activity. Predicted to be located in extracellular space. Predicted to be part of collagen trimer. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
333 residues, UniProt reviewed canonical sequence.
>B2RNN3|C1QTNF9B
1 MRIWWLLLAI EICTGNINSQ DTCRQGHPGI PGNPGHNGLP GRDGRDGAKG DKGDAGEPGC
61 PGSPGKDGTS GEKGERGADG KVEAKGIKGD QGSRGSPGKH GPKGLAGPMG EKGLRGETGP
121 QGQKGNKGDV GPTGPEGPRG NIGPLGPTGL PGPMGPIGKP GPKGEAGPTG PQGEPGVRGI
181 RGWKGDRGEK GKIGETLVLP KSAFTVGLTV LSKFPSSDVP IKFDKILYNE FNHYDTAVGK
241 FTCHIAGVYY FTYHITVFSR NVQVSLVKNG VKILHTRDAY VSSEDQASGS IVLQLKLGDE
301 MWLQVTGGER FNGLFADEDD DTTFTGFLLF SSQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against C1QTNF9B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- skin: 17 nTPM
- hippocampal formation: 9.5 nTPM
- testis: 8.3 nTPM
- prostate: 4 nTPM
- skeletal muscle: 3.8 nTPM
- heart muscle: 3.3 nTPM
Single-cell type
- undifferentiated spermatogonia: 3.6 nCPM
- cardiomyocytes: 3.3 nCPM
- late spermatids: 3.2 nCPM
- brain excitatory neurons: 2.4 nCPM
- early spermatids: 1.9 nCPM
- late primary spermatocytes: 0.9 nCPM
Immune cell
- plasmacytoid DC: 0.7 nTPM
- naive B-cell: 0.5 nTPM
- eosinophil: 0.4 nTPM
- NK-cell: 0.4 nTPM
- non-classical monocyte: 0.4 nTPM
- gdT-cell: 0.3 nTPM
Brain region
- hippocampal formation: 17 nTPM
- hypothalamus: 4.1 nTPM
- cerebral cortex: 2.4 nTPM
- amygdala: 2.3 nTPM
- basal ganglia: 2 nTPM
- midbrain: 1.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.5
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.18
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of C1QTNF9B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
- ADIPOQ
- CTRP9A
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads C1QTNF9B as an antibody target. Whether an autoantibody or antibody against C1QTNF9B could matter depends on whether native C1QTNF9B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
C1QTNF9B is annotated as secreted, so native C1QTNF9B circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label C1QTNF9B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...